AfimaCheck

Toronto, Canada Founded: 2021 • Age: 5 yrs
Developer of thermal reader technology for onsite drug testing applications
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About AfimaCheck

AfimaCheck is a company based in Toronto (Canada) founded in 2021 by Nima Tabatabaei. AfimaCheck offers products and services including Assay Reader and Thermophotonic Technology. AfimaCheck operates in a competitive market with competitors including Intelligent Fingerprinting, Detect, Confirm BioSciences, Safety Strips and Portable Diagnostic Systems, among others.

  • Headquarter Toronto, Canada
  • Founders Nima Tabatabaei
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Afimacheck Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AfimaCheck

AfimaCheck offers a comprehensive portfolio of products and services, including Assay Reader and Thermophotonic Technology.

Product name locked
Category locked
Primary

Improves LFA sensitivity for accurate drug and disease detection

Product name locked
Category locked
Locked

Enables quantitative measurements on existing Lateral Flow Assays

Funding Insights of AfimaCheck

Premium access

Detailed funding history for AfimaCheck

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AfimaCheck

Investments
Premium access

Investment portfolio details for AfimaCheck

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - AfimaCheck

Premium access

Detailed financials for AfimaCheck

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Afimacheck Comparisons

AfimaCheck Primary company
Description
Developer of thermal reader technology for onsite drug testi...
Location
Toronto, Canada
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for AfimaCheck

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of AfimaCheck

AfimaCheck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intelligent Fingerprinting, Detect, Confirm BioSciences, Safety Strips and Portable Diagnostic Systems, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Non-invasive drug testing technology is developed using fingerprints.
Locked Locked Locked
Diagnostics for women’s health are transformed through innovative solutions.
Locked Locked Locked
Tools and solutions for drug and health testing are provided.
Locked Locked Locked
Fentanyl test strips are supplied for harm reduction efforts.
Locked Locked Locked
Developer of drug screening device for medical exams and law enforcement
Locked Locked Locked
Offers digital devices for at-home health monitoring, diagnosis, and data sharing services.
Premium access

Detailed competitors of AfimaCheck

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Afimacheck

Premium access

Complete news archive for AfimaCheck

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AfimaCheck

AfimaCheck was founded in 2021.

AfimaCheck is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Chris Schwartze is the current CEO of AfimaCheck.

AfimaCheck was founded in 2021 in Toronto, Canada, within the health technology sector. Thermal reader technology is developed for onsite applications, including the AfimaCheck Reader, which detects drugs of abuse in saliva for safety-sensitive roles. Photothermal detection methods are employed, utilizing laser stimulation and infrared sensors to quantify SARS-CoV-2 antibodies. Operations focus on rapid, reliable testing solutions for various professional environments.

AfimaCheck's top competitors include Intelligent Fingerprinting, Safety Strips and Confirm BioSciences.

AfimaCheck offers Assay Reader and Thermophotonic Technology.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available